ライフサイエンスコーパス: pterygium

1 inoma, 1 sebaceous carcinoma, and 1 atypical pterygium.

2 nical behavior between primary and recurrent pterygium.

3 , followed by bipolar (8%) and temporal (3%) pterygium.

4 toaging, including ocular surface tumors and pterygium.

5 al granuloma, wound dehiscence, and residual pterygium.

6 pemphigoid, vernal keratoconjunctivitis, and pterygium.

7 Eighty-nine adult patients with primary pterygium.

8 with amniotic membrane transplant (AMT) for pterygium.

9 rgery on patients with primary and recurrent pterygium.

10 rygium, but scarce from those with recurrent pterygium.

11 eoplasia is uncommonly found to coexist with pterygium.

12 on patterns of HCC in normal conjunctiva and pterygium.

13 rials reporting on surgical intervention for pterygium.

14 lone in most studies of primary or recurrent pterygium.

15 recurrence rate after surgical excision of a pterygium.

16 examine the anterior segment for evidence of pterygium.

17 vel (P<0.001) as significant factors for any pterygium.

18 he relationship of race and other factors to pterygium.

19 were identified as contributing to childhood pterygium.

20 ce in 45 individuals (32.6% of patients with pterygium; 0.8% of study population).

21 on (38%) histological diagnosis, followed by pterygium (36%) and actinic keratosis (19%).

22 contributed significantly to presence of any pterygium (41%; P<0.001) or presence in both eyes (33%;

23 However, the recurrence rate of pterygium after surgery can be high.

24 ignificant difference in recurrence rates of pterygium after surgery with mitomycin C application bet

25 of resources, primary or recurrent status of pterygium, age of patient, and surgeon or patient prefer

26 ribed the clinical features of patients with pterygium and analyzed the recurrence rate of conjunctiv

27 l was further elevated in patients with both pterygium and demodicosis (all P<0.05).

28 e of 16 years, consecutively presenting with pterygium and evaluated at a single tertiary care center

29 he clinical characteristics of patients with pterygium and evaluated the recurrence rates of three tr

30 of pterygium is dependent on the grading of pterygium and its clinical presentation (inflamed or qui

31 ents were divided into the following groups: pterygium and no OSSN (group 1), clinically suspected OS

32 biological samples taken from patients with pterygium and normal volunteers, whom were operated unde

33 his lesion frequently occurs in pre-existing pterygium and pinguecula and may be associated with alle

34 and specificity in differentiating OSSN from pterygium and pinguecula.

35 have clinical implications on progression of pterygium and recurrence associated with incomplete exci

36 with several external eye diseases including pterygium and squamous metaplasia or carcinoma.

37 Any type of eye surgery, extensive pterygium, and lack of cooperation were used as exclusio

38 SSN mirrors that of OSSN not associated with pterygium, and thus vigilance for recurrence is importan

39 n, classification of pterygium, width of the pterygium at limbus, surgical technique (conjunctival au

40 raft as the preferred surgical technique for pterygium because of the low recurrence and complication

41 added at 10 ng/ml to early passaged primary pterygium body fibroblasts (PBF) or normal human conjunc

42 data is available from patients with primary pterygium, but scarce from those with recurrent pterygiu

43 At the 1-year follow-up, 393 pterygium cases in 343 eyes were assessed.

44 Most pterygium cases presented as primary and in the nasal ar

45 Pterygium causes errors in IOL power calculation, with g

46 We cultured primary pterygium cells from pterygium tissues from Hispanic and

47 matrix and myofibroblast markers in cultured pterygium cells.

48 s of HCC mRNAs and proteins were detected in pterygium compared with a normal conjunctiva.

49 Ocular pterygium-digital keloid dysplasia (OPDKD) presents in c

50 All the eyes had primary pterygium, except 1, which was recurrent.

51 Ten patients undergoing pterygium excision and femtosecond laser-assisted CAG tr

52 in place of conjunctival autografting after pterygium excision and to reconstruct the conjunctival s

53 C further reduces the recurrence rate after pterygium excision compared with conjunctival or limbal

54 All eyes underwent pterygium excision followed by removal of subconjunctiva

55 ry during conjunctival transplantation after pterygium excision have not been answered fully.

56 However, diplopia after pterygium excision in primary position is surgically cor

57 al autografts or mitomycin C during or after pterygium excision reduced recurrence compared with bare

58 ust 2007, consecutive subjects indicated for pterygium excision were enrolled from an outpatient eye

59 age = 49 years) who developed diplopia after pterygium excision were included.

60 0 eyes with primary pterygium that underwent pterygium excision with a conjunctival autograft.

61 recurrence rates of three treatment methods: pterygium excision with conjunctival autograft (CAG), pt

62 Four eyes (15%) required surgery, where pterygium excision with conjunctival-limbal autograft wi

63 excision with conjunctival autograft (CAG), pterygium excision with dehydrated amniotic membrane gra

64 Given the high volume of pterygium excision, awareness of postoperative restricti

65 e diplopia is a potential complication after pterygium excision, particularly for patients with a his

66 15 patients with restrictive diplopia after pterygium excision.

67 and sight-threatening complication following pterygium excision.

68 All patients underwent pterygium extended removal followed by extended conjunct

69 Pterygium extended removal followed by extended conjunct

70 ion is the final choice of treatment for the pterygium extending beyond the limbus.

71 Simple excision or resection of the pterygium followed by conjunctival autografting or intra

72 terygium (group 2), and unexpected OSSN with pterygium found on histopathology (group 3).

73 pared to the control group, in the recurrent pterygium group there was a significant decrease in the

74 ompared to the control group, in the primary pterygium group there was an increase in NO and TAS, and

75 s within the control group and the recurrent pterygium group, but not within the primary pterygium gr

76 inished antioxidant defense in the recurrent pterygium group, possibly determined mainly by decreased

77 pterygium group, but not within the primary pterygium group.

78 el and low TAS level of women in the prymary pterygium group.

79 SN (group 1), clinically suspected OSSN with pterygium (group 2), and unexpected OSSN with pterygium

80 The primary outcome was recurrence of pterygium >/=1 mm onto the cornea by 3 and 6 months post

81 Pterygium is a disorder of the ocular surface induced by

82 Development of pterygium is a possibility in younger age groups.

83 Pterygium is also a health disparity issue since it is m

84 Pterygium is an important illness that affects 22% peopl

85 Pterygium is an ocular disease in which the conjunctival

86 Management of pterygium is dependent on the grading of pterygium and i

87 The mean pterygium length was 2.08 +/- 0.58 mm, and the mean area

88 We analyzed correlations between pterygium length/area and IOL power, as well as corneal

89 rrors in IOL power calculation, with greater pterygium length/area exerting a larger effect.

90 ld be decreased by 0.5 to 1.5 D based on the pterygium length/area.

91 agnosis was pterygium (n = 4, 50%), inflamed pterygium (n = 1, 13%), pterygium vs conjunctival squamo

92 Clinical diagnosis was pterygium (n = 4, 50%), inflamed pterygium (n = 1, 13%),

93 Tears from patients with pterygium (n = 50) and normal volunteers (n = 24) were o

94 cally, actinic granuloma was associated with pterygium (n = 6, 75%) and pinguecula (n = 2, 25%).

95 ected included: date of service; location of pterygium (nasal, temporal, or both); primary or recurre

96 age, gender, surgical history for cataract, pterygium or conjunctivochalasis, and artificial tear us

97 significantly higher in patients with either pterygium or demodicosis than controls (P = 0.049 and 0.

98 ders into "OSSN or suspicious for OSSN" and "pterygium or pinguecula." The algorithm's diagnostic per

99 g a surgical history of cataract (P = .037), pterygium, or conjunctivochalasis (P = .014).

100 defect to cover as in primary double-headed pterygium, or in the context of preserving superior bulb

101 clinical or biopsy-proven diagnosis of OSSN, pterygium, or pinguecula that received AS-OCT imaging.

102 recurrent pterygium than those with primary pterygium (P = 0.015).

103 ients (6.9%) in the LCAU group had recurrent pterygium (P = 0.021).

104 tuted 7.4% of primary and 12.2% of recurrent pterygium (P = 0.820).

105 67) in OSSN patients and 101 mum (SD, 22) in pterygium patients (P<0.001).

106 an study population aged 40+ years, a higher pterygium prevalence (mean: 2.3%) was correlated with ol

107 Mean pterygium prevalence (per individual) was 138/5888 (2.3%

108 Pterygium prevalence increased from 0.8% (95% CI: 0.02,

109 In multivariable analysis, higher pterygium prevalence was associated with older age (P =

110 03; OR: 0.89; 95% CI: 0.81, 0.99), while the pterygium prevalence was statistically independent of se

111 Pterygium recurrence 6 months after surgery ranged from

112 Pterygium recurrence and postoperative morbidity remain

113 ective than intraoperative MMC in minimizing pterygium recurrence at the 10-year follow-up.

114 CAG was more effective than AMT to prevent pterygium recurrence by 6 months post surgery, especiall

115 The pterygium recurrence rate at last follow-up (OR = 0.32;

116 ated statistically significant reductions in pterygium recurrence rate for randomized clinical trials

117 and Web of Science for trials that compared pterygium recurrence rates between excision surgery with

118 ical 0.05% CsA appears effective in reducing pterygium recurrence rates following bare sclera and CFR

119 Rho kinase inhibitor can be used to prevent pterygium recurrence since its anti-fibrosis effects hav

120 duced markedly, as were flap dislocation and pterygium recurrence with Tisseel fibrin glue compared w

121 Ocular demodicosis is a risk factor for pterygium recurrence, especially for conjunctival recurr

122 Pterygium recurrence, patient discomfort level, and surg

123 nflammation may be a new strategy to prevent pterygium recurrence.

124 potential post-surgical treatment to prevent pterygium recurrence.

125 refractive change (SIRC), complications, and pterygium recurrence.

126 mbrane graft surgery in reducing the rate of pterygium recurrence.

127 surgery, no eye in the CLAU group developed pterygium recurrence; however, recurrence was seen in 2

128 dence indicates that bare sclera excision of pterygium results in a significantly higher recurrence r

129 Factors associated with pterygium severity and recurrence were analyzed by univa

130 ystrophy, Salzmann nodular degeneration, and pterygium, should be addressed proactively.

131 nce of close follow-up examination following pterygium surgeries.

132 operative outcomes of patients who underwent pterygium surgery at an ambulatory eye center in the Phi

133 of 462 eyes from 408 patients who underwent pterygium surgery by a single surgeon between February 2

134 of our knowledge, Klebsiella keratitis after pterygium surgery has not been described in the current

135 Pterygium surgery is the most commonly performed ocular

136 The average cost of office-based pterygium surgery was $1795 ($1700-$1890, depending on s

137 repositioning of conjunctival autografts in pterygium surgery was associated with a similar function

138 To evaluate the outcome of pterygium surgery with conjunctival autograft using Vicr

139 Patients undergoing pterygium surgery with conjunctival autografting were ra

140 ive merits of the various techniques used in pterygium surgery with particular reference to the growi

141 One year after pterygium surgery, the calculated IOL power values using

142 implantation is recommended >=6 months after pterygium surgery.

143 operative discomfort than sutures in primary pterygium surgery.

144 securing conjunctival autografts in primary pterygium surgery.

145 paring fibrin glue versus sutures in primary pterygium surgery.

146 e risk factors that influence the success of pterygium surgery.

147 She had a history of pterygium surgical excision two months ago.

148 tient with corneal ulcer formation following pterygium surgical excision.

149 Multiple pterygium syndrome (MPS) is a phenotypically and genetic

150 Van der Woude syndrome (VWS) and popliteal pterygium syndrome (PPS) are autosomal dominant disorder

151 Popliteal pterygium syndrome (PPS; OMIM 119500) is a disorder with

152 y of IRF6 causes Van der Woude and popliteal pterygium syndrome, 2 syndromic forms of cleft lip and p

153 vastating birth defects, including popliteal pterygium syndrome, cocoon syndrome, and Bartsocas-Papas

154 sorders Van der Woude syndrome and popliteal pterygium syndrome, have a hyperproliferative epidermis

155 rders Bartsocas-Papas syndrome and popliteal pterygium syndrome, respectively.

156 nderlie Van der Woude syndrome and popliteal pterygium syndrome.

157 Multiple pterygium syndromes (MPS) comprise a group of multiple c

158 Multiple pterygium syndromes (MPSs) comprise a group of multiple-

159 Pterygium syndromes are complex congenital disorders tha

160 individuals with Van der Woude and popliteal pterygium syndromes, suggesting that the TGFbeta/SMAD4/I

161 the cascade of molecular events that prevent pterygium syndromes.

162 as more prevalent in patients with recurrent pterygium than those with primary pterygium (P = 0.015).

163 We enrolled 30 eyes with primary pterygium that underwent pterygium excision with a conju

164 For 96 eyes with recurrent pterygium, the risk of recurrence 6 months after CAG was

165 When the pterygium tissue reaches the pupillary region, the visua

166 We cultured primary pterygium cells from pterygium tissues from Hispanic and Latino American, Afr

167 protein in tears was higher in patients with pterygium versus controls.

168 = 4, 50%), inflamed pterygium (n = 1, 13%), pterygium vs conjunctival squamous cell carcinoma (n = 1

169 The overall prevalence of any pterygium was 10.1% (n = 900), of which severe pterygium

170 Severe pterygium was associated with outdoor occupation (P = 0.

171 A retrospective cohort study of primary pterygium was conducted between January 2017 and Februar

172 nly factor associated with the recurrence of pterygium was dry eye disease.

173 The prevalence of any pterygium was more common in Malays (15.5%) than Chinese

174 A pterygium was not a biomarker for an internal medical di

175 erygium was 10.1% (n = 900), of which severe pterygium was seen in 1.6% (n = 142).

176 Nasal pterygium was the most common type (72%), followed by bi

177 urrence, but the morphologic features of the pterygium were shown to affect the recurrence rate.

178 A total of 448 eyes (50.22%) with pterygium were treated with adjuvant 0.05% CsA.

179 tal of 115 eyes of 114 patients with primary pterygium were treated with intraoperative MMC (n = 63)

180 ell carcinoma, 2 lymphomas, and 3 pinguecula/pterygium) while the other 30, presenting no reflectance

181 ures against UV-radiation, classification of pterygium, width of the pterygium at limbus, surgical te

182 d that race is a significant risk factor for pterygium, with Malays having higher prevalence than Ind